Contact information
Type
Scientific
Primary contact
Mr Rami Jumnoodoo
ORCID ID
Contact details
Trust
Park Royal MH Centre
Twyford Centre
Acton lane
Central Way
London
NW10 7NS
United Kingdom
+44 (0)208 453 2779
rami.jumnoodoo@nhs.net
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N0195129515
Study information
Scientific title
Acronym
Study hypothesis
Whether a prescribed course of relapse prevention therapy (RPT), based on Marlatts model, may have a statistically significant higher knowledge score post-group; whether there will be a significant reduction of inpatient bed nights and whether there will be a statistically significant degree of contact maintenance with helping services by comparison with the comparison group?
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Other
Trial type
Treatment
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Mental and Behavioural Disorders: Schizophrenia
Intervention
For the experimental group, there will be a semi structured interview questionnaire at pre and post relapse prevention therapy (RPT) and at 5 weeks follow up. For the control group, there will be a semi structured questionnaire to be completed at the same time as that of the experimental group and afterwards at 3 months interval to ensure matching time intervals. In addition there will be a demographic characteristic form to complete on ever participant.
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measures
Relapse prevention skills and knowledge, reduction of in-patient hospitalisation and an improvement in maintaining contact with helping services.
Secondary outcome measures
Not provided at time of registration
Overall trial start date
08/07/2002
Overall trial end date
16/06/2003
Reason abandoned
Lack of staff/facilities/resources
Eligibility
Participant inclusion criteria
Patients with a primary diagnosis of schizophrenia (International Statistical Classification of Diseases and Related Health Problems - tenth revision [ICD10] = F20-29)
Participant type
Patient
Age group
Not Specified
Gender
Not Specified
Target number of participants
Not provided at time of registration
Participant exclusion criteria
Does not meet inclusion criteria
Recruitment start date
08/07/2002
Recruitment end date
16/06/2003
Locations
Countries of recruitment
United Kingdom
Trial participating centre
Trust
London
NW10 7NS
United Kingdom
Sponsor information
Organisation
Department of Health
Sponsor details
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Sponsor type
Government
Website
Funders
Funder type
Other
Funder name
London West Mental R&D Consortium (UK)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary